{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T00:28:51Z","timestamp":1787963331005,"version":"build-2784847793"},"reference-count":45,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T00:00:00Z","timestamp":1750723200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100023324","name":"Salale University","doi-asserted-by":"publisher","award":["25000 Ethiopian Birr"],"award-info":[{"award-number":["25000 Ethiopian Birr"]}],"id":[{"id":"10.13039\/501100023324","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Despite evidence suggesting that hyperuricemia (serum uric acid &gt;7.0\u2009mg\/dL in males and &gt;6.0\u2009mg\/dL in females) contributes to adverse outcomes like mortality and hospitalization in patients with cardiovascular disease (CVD), a comprehensive understanding of its magnitude is still lacking, underscoring the need for further investigation. There is no previously published study about hyperuricemia in cardiovascular disease in Ethiopia. Therefore, this study aims to investigate the prevalence of hyperuricemia and its associated factors among adult patients with cardiovascular diseases at Salale University Compressive Specialized Hospital Located in Fitche, Ethiopia (115 km north of Addis Ababa),from October 1, 2023, to January 28, 2024.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Materials and methods<\/jats:title>\n<jats:p>A hospital-based cross-sectional study was conducted on 298 participants with different types of cardiovascular disease. The participants were selected using a consecutive sampling technique. Socio-demographic factors were collected using interviewer-administered questionnaires, while overnight blood samples were collected and biochemical tests were analyzed using the COBAS c 311 automated clinical chemistry analyzer. Descriptive statistics and logistic regression analyses were performed. A variable that had a p-value of \u2264 0.05 with a 95% confidence interval was considered statistically significant.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Result<\/jats:title>\n<jats:p>The prevalence of hyperuricemia among adult cardiovascular disease patients was 41.3% CI [35.6\u201347.1]. The highest prevalence of hyperuricemia was found among cardiovascular disease patients with congestive heart failure (48.0%) and hypertensive heart disease (41.2%). Factors such as physical activity (AOR: 4.1; 95% CI: 1.5\u201310.7, P\u2009=\u20090.004), dyslipidemia (AOR: 2.7; 95% CI: 1.2\u20136.0, P\u2009=\u20090.01) and chronic kidney disease (AOR: 3.1; 95% CI: 1.5\u20136.1, P\u2009=\u20090.001) were found to be associated with hyperuricemia among individuals with cardiovascular disease.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion<\/jats:title>\n<jats:p>The study indicated a high prevalence of hyperuricemia among participants with cardiovascular disease. Physical activity, dyslipidemia, and chronic kidney disease were recognized as significant associated factors of hyperuricemia among cardiovascular disease. Therefore, early diagnosis of hyperuricemia and its management is essential to control complications and extend the life expectancy of individuals with cardiovascular disease.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0325775","type":"journal-article","created":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T17:28:47Z","timestamp":1750786127000},"page":"e0325775","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":4,"title":["Hyperuricemia and associated factors among adult cardiovascular disease patients at Salale University Comprehensive Specialized Hospital, Fitche, Central Ethiopia"],"prefix":"10.1371","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-2818-0712","authenticated-orcid":true,"given":"Negesse Bokona","family":"Rufe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-2454-2760","authenticated-orcid":true,"given":"Tolera Ambisa","family":"Lamesa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aklilu Getachew","family":"Mamo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Belay Merkeb","family":"Zewude","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bedasa","family":"Addisu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deresa Jamma","family":"Nigusie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1720-8011","authenticated-orcid":true,"given":"Sintayehu Asaye","family":"Biya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2025,6,24]]},"reference":[{"issue":"8","key":"pone.0325775.ref001","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.3390\/biomedicines10081938","article-title":"Pathophysiology of cardiovascular diseases: new insights into molecular mechanisms of atherosclerosis, arterial hypertension, and coronary artery disease","volume":"10","author":"W Fr\u0105k","year":"2022","journal-title":"Biomedicines"},{"issue":"1","key":"pone.0325775.ref002","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1186\/s12889-021-10429-0","article-title":"Trend analysis of cardiovascular disease mortality, incidence, and mortality-to-incidence ratio: results from global burden of disease study 2017","volume":"21","author":"M Amini","year":"2021","journal-title":"BMC Public Health"},{"issue":"12","key":"pone.0325775.ref003","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0267527","article-title":"Assessment of magnitude and spectrum of cardiovascular disease admissions and outcomes in Saint Paul Hospital Millennium Medical College, Addis Ababa: A retrospective study, Sasso FC, editor","volume":"17","author":"MD Mengistu","year":"2022","journal-title":"PLOS ONE"},{"key":"pone.0325775.ref004","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.biomaterials.2018.09.036","article-title":"Cardiovascular disease models: A game changing paradigm in drug discovery and screening","volume":"198","author":"H Savoji","year":"2019","journal-title":"Biomaterials"},{"issue":"1","key":"pone.0325775.ref005","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.icte.2021.08.021","article-title":"A comparative study of classification and prediction of Cardio-Vascular Diseases (CVD) using Machine Learning and Deep Learning techniques","volume":"8","author":"M Swathy","year":"2022","journal-title":"ICT Express"},{"key":"pone.0325775.ref006","doi-asserted-by":"crossref","DOI":"10.1016\/j.amsu.2022.104522","article-title":"Time to relook into non-communicable diseases (NCDs) in Africa: a silent threat overwhelming global health in Africa","volume":"82","author":"A Owolade","year":"2022","journal-title":"Ann Med Surg"},{"issue":"10","key":"pone.0325775.ref007","article-title":"World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions","volume":"7","author":"WHO CVD Risk Chart Working Group","year":"2019","journal-title":"Lancet Glob Health"},{"key":"pone.0325775.ref008","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.2147\/IJGM.S308158","article-title":"Hyperuricemia and its associated factors among adult staff members of the Ethiopian Public Health Institute, Ethiopia","volume":"14","author":"MD Molla","year":"2021","journal-title":"Int J Gen Med"},{"issue":"1","key":"pone.0325775.ref009","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1186\/s12872-023-03348-y","article-title":"Dyslipidemia and its associated factors among adult cardiac patients at Ambo university referral hospital, Oromia region, west Ethiopia","volume":"23","author":"B Addisu","year":"2023","journal-title":"BMC Cardiovasc Disord"},{"key":"pone.0325775.ref010","doi-asserted-by":"crossref","first-page":"132527","DOI":"10.1016\/j.ijcard.2024.132527","article-title":"Uric acid and metabolic syndrome: Importance of hyperuricemia cut-off","volume":"417","author":"A Maloberti","year":"2024","journal-title":"Int J Cardiol"},{"key":"pone.0325775.ref011","doi-asserted-by":"crossref","first-page":"582680","DOI":"10.3389\/fphar.2020.582680","article-title":"Uric acid and cardiovascular disease: An update from molecular mechanism to clinical perspective","volume":"11","author":"W Yu","year":"2020","journal-title":"Front Pharmacol"},{"issue":"1","key":"pone.0325775.ref012","first-page":"53","article-title":"Clinical implications of uric acid in heart failure: a comprehensive review","volume":"11","author":"M Kumri\u0107","year":"2021","journal-title":"Life (Basel)"},{"key":"pone.0325775.ref013","doi-asserted-by":"crossref","first-page":"770815","DOI":"10.3389\/fendo.2021.770815","article-title":"Hyperuricemia and the risk of heart failure: pathophysiology and therapeutic implications","volume":"12","author":"K Si","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"pone.0325775.ref014","doi-asserted-by":"crossref","first-page":"817150","DOI":"10.3389\/fmed.2021.817150","article-title":"The association of hyperuricemia and gout with the risk of cardiovascular diseases: a cohort and mendelian randomization study in UK Biobank","volume":"8","author":"J Zhu","year":"2022","journal-title":"Front Med"},{"key":"pone.0325775.ref015","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.cca.2018.05.046","article-title":"Uric acid and cardiovascular disease","volume":"484","author":"G Ndrepepa","year":"2018","journal-title":"Clin Chim Acta"},{"issue":"5","key":"pone.0325775.ref016","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1093\/eurheartj\/ehy686","article-title":"Corrigendum to: 2018 ESC\/ESH Guidelines for the management of arterial hypertension","volume":"40","year":"2019","journal-title":"Eur Heart J"},{"issue":"1","key":"pone.0325775.ref017","doi-asserted-by":"crossref","first-page":"109","DOI":"10.4103\/JCMRP.JCMRP_9_19","article-title":"Possibility of association of hypertension and ischemic heart disease with primary hyperuricemia","volume":"5","author":"NDAEAM Elhefny","year":"2020","journal-title":"J Curr Med Res Pract"},{"issue":"3","key":"pone.0325775.ref018","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.37358\/RC.19.3.7060","article-title":"Hyperuricemia and cardiovascular diseases clinical and paraclinical correlations","volume":"70","author":"D Timofte","year":"2019","journal-title":"Rev Chim"},{"issue":"6","key":"pone.0325775.ref019","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1159\/000503058","article-title":"Hyperuricemia in US population with heart failure: causal or incidental bystander?","volume":"9","author":"G Ruocco","year":"2019","journal-title":"Cardiorenal Med"},{"issue":"1","key":"pone.0325775.ref020","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3390\/jcm12010050","article-title":"Prevalence of hyperuricemia and its association with cardiovascular risk factors and subclinical target organ damage","volume":"12","author":"P Antelo-Pais","year":"2022","journal-title":"J Clin Med"},{"key":"pone.0325775.ref021","doi-asserted-by":"crossref","unstructured":"Fadhlullah A, Balha A, Abdalgwad R. The association between coronary artery disease and hyperuricemia in Libyan adults: a cross-sectional study. 2021;65\u20138.","DOI":"10.47705\/kjdmr.216111"},{"issue":"9","key":"pone.0325775.ref022","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0256557","article-title":"Evaluation of uric acid disorders and associated factors in essential hypertensive patients at Wolkite University specialized hospital, Southern Ethiopia. Zago AS, editor","volume":"16","author":"A Timerga","year":"2021","journal-title":"PLoS One"},{"issue":"3","key":"pone.0325775.ref023","doi-asserted-by":"crossref","first-page":"191","DOI":"10.4103\/jpcs.jpcs_48_19","article-title":"Prevalence and determinants of hyperuricemia in South Indian adult patients with stable coronary artery disease","volume":"5","author":"S Patil","year":"2019","journal-title":"J Pract Cardiovasc Sci"},{"issue":"51","key":"pone.0325775.ref024","article-title":"The association between hyperuricemia and cardiovascular disease history: A cross-sectional study using KoGES HEXA data","volume":"101","author":"JH Kim","year":"2022","journal-title":"Med (Baltimore)"},{"issue":"4","key":"pone.0325775.ref025","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/s41440-021-00840-w","article-title":"Impact of hyperuricemia on chronic kidney disease and atherosclerotic cardiovascular disease","volume":"45","author":"H Nishizawa","year":"2022","journal-title":"Hypertens Res"},{"issue":"1","key":"pone.0325775.ref026","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5603\/CJ.a2021.0001","article-title":"Expert consensus for the diagnosis and treatment of patient with hyperuricemia and high cardiovascular risk: 2021 update","volume":"28","author":"C Borghi","year":"2021","journal-title":"Cardiol J"},{"key":"pone.0325775.ref027","unstructured":"A healthy lifestyle - WHO recommendations. 2023."},{"key":"pone.0325775.ref028","first-page":"1","volume-title":"Operator\u2019s Manual","author":"Diagnostics R","year":"2016"},{"key":"pone.0325775.ref029","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.2147\/DMSO.S252825","article-title":"Prevalence and determinants of hyperuricemia in type 2 diabetes mellitus patients attending Jimma Medical Center, southwestern Ethiopia, 2019","author":"KK Arersa","year":"2020","journal-title":"Diabetes Metab Syndr Obes Targets Ther"},{"key":"pone.0325775.ref030","doi-asserted-by":"crossref","DOI":"10.1002\/clc.4960261505","article-title":"New features of the National Cholesterol Education Program Adult Treatment Panel III lipid-lowering guidelines","volume":"26","author":"HB Brewer","year":"2003","journal-title":"Clin Cardiol"},{"key":"pone.0325775.ref031","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2021\/5515832","article-title":"Prevalence and associated factors of chronic kidney disease among adult hypertensive patients at Northwest Amhara referral hospitals, Northwest Ethiopia, 2020. Moreira TMM, editor","volume":"2021","author":"A Hunegnaw","year":"2021","journal-title":"Int J Hypertens"},{"key":"pone.0325775.ref032","first-page":"450","volume-title":"Global status report on alcohol and health 2018 [Internet]","author":"World Health Organization","year":"2018"},{"issue":"24","key":"pone.0325775.ref033","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1136\/bjsports-2020-102955","article-title":"World Health Organization 2020 guidelines on physical activity and sedentary behaviour","volume":"54","author":"FC Bull","year":"2020","journal-title":"Br J Sports Med"},{"issue":"1","key":"pone.0325775.ref034","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/s12872-019-1215-z","article-title":"Serum uric acid and risk of cardiovascular mortality: a systematic review and dose-response meta-analysis of cohort studies of over a million participants","volume":"19","author":"F Rahimi-Sakak","year":"2019","journal-title":"BMC Cardiovasc Disord"},{"key":"pone.0325775.ref035","doi-asserted-by":"crossref","DOI":"10.34172\/jpd.2023.11174","article-title":"Role of hyperuricemia in cardiovascular disease and its treatment options: A review article","volume":"11","author":"F Kafi","year":"2023","journal-title":"J Parathyr Dis"},{"issue":"2","key":"pone.0325775.ref036","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s42399-019-00203-0","article-title":"Hyperuricemia and cardiovascular diseases in very elderly patients with coronary artery disease","volume":"2","author":"SV Topolyanskaya","year":"2020","journal-title":"SN Compr Clin Med"},{"key":"pone.0325775.ref037","unstructured":"Mehmood K, Pervez A, Hussain M, Taj A, Sawar S, Zahoor M. Frequency of hyperuricemia in patients with heart diseases. 2019;12:302\u20135."},{"issue":"1","key":"pone.0325775.ref038","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1186\/s40001-022-00888-5","article-title":"Prevalence and influence of hypouricemia on cardiovascular diseases in patients with rheumatoid arthritis","volume":"27","author":"Y-W Zou","year":"2022","journal-title":"Eur J Med Res"},{"key":"pone.0325775.ref039","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.amjcard.2021.05.007","article-title":"Relation of serum uric acid and cardiovascular events in young adults aged 20-49 years","volume":"152","author":"H Seki","year":"2021","journal-title":"Am J Cardiol"},{"issue":"8","key":"pone.0325775.ref040","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.3390\/nu10081011","article-title":"Different risk for hypertension, diabetes, dyslipidemia, and hyperuricemia according to level of body mass index in Japanese and American subjects","volume":"10","author":"M Kuwabara","year":"2018","journal-title":"Nutrients"},{"issue":"10","key":"pone.0325775.ref041","article-title":"Association between hyperuricemia and acute ischemic stroke in patients at a Tertiary Care Hospital","volume":"12","author":"M Irfan","year":"2020","journal-title":"Cureus"},{"issue":"2","key":"pone.0325775.ref042","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.numecd.2023.10.019","article-title":"Hyperuricemia is associated with heart failure readmission in patients with heart failure and preserved ejection fraction-an observational study in Chinese","volume":"34","author":"X Liu","year":"2024","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"8","key":"pone.0325775.ref043","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.3390\/biomedicines11082212","article-title":"Elevated uric acid levels with early chronic kidney disease as an indicator of new-onset ischemic heart disease: a cohort of Koreans without diabetes","volume":"11","author":"S-B Lee","year":"2023","journal-title":"Biomedicines"},{"issue":"5","key":"pone.0325775.ref044","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.jare.2017.03.003","article-title":"Physiological functions and pathogenic potential of uric acid: A review","volume":"8","author":"R El Ridi","year":"2017","journal-title":"J Adv Res"},{"issue":"1","key":"pone.0325775.ref045","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s40885-020-00146-y","article-title":"Uric acid and cardiometabolic diseases","volume":"26","author":"SJ Lee","year":"2020","journal-title":"Clin Hypertens"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0325775","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T17:29:00Z","timestamp":1750786140000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0325775"}},"subtitle":[],"editor":[{"given":"Paolo","family":"Magni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,6,24]]},"references-count":45,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,6,24]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0325775","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,24]]}}}